mutation carrier
Showing 1 - 25 of 2,943
Natural History Study - Mitochondrial Disease
Recruiting
- MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier
-
New York, New YorkColumbia University
Jul 28, 2022
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,
Active, not recruiting
- BRCA1 Mutation Carrier
- +8 more
- soy isoflavones
- +7 more
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2021
Clinical Phenotypic Characteristics of SC26A4
Recruiting
- Hearing Loss
- Pendred Syndrome
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 24, 2023
Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,
Active, not recruiting
- Endometrial Adenocarcinoma
- +3 more
- Genetic Counseling
- +3 more
-
Akron, Ohio
- +8 more
Dec 2, 2022
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Breast Cancer, Hereditary Breast and Ovarian Cancer Trial in United States
Recruiting
- Breast Cancer
- Hereditary Breast and Ovarian Cancer
-
Hays, Kansas
- +12 more
Apr 4, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- +10 more
- (no location specified)
Jan 13, 2023
Patients With Peroxisome Biogenesis Disorders (PBD)
Recruiting
- Peroxisome Biogenesis Disorder
- +10 more
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Jul 4, 2022
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Digital Genetic Counselor for BRCA1/2 Mutation Carrier Testing
Unknown status
- BRCA Mutations
- (no location specified)
Jan 29, 2020
Amyloid Neuropathies, Transthyretin Amyloidosis Trial in Marseille (Electrophysiological biomarkers, MRI biomarkers)
Completed
- Amyloid Neuropathies
- Transthyretin Amyloidosis
- Electrophysiological biomarkers
- MRI biomarkers
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Oct 2, 2022
Hereditary Spastic Paraplegia, Hereditary, Spastic Paraplegia, Autosomal Dominant Trial in Tübingen (other, behavioral,
Recruiting
- Hereditary Spastic Paraplegia
- Hereditary, Spastic Paraplegia, Autosomal Dominant
- SPRS Score and clinical signs
- +6 more
-
Tübingen, GermanyUniversity Hospital Tübingen, Center for Neurology
Aug 18, 2022
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
Completed
- Li-Fraumeni Syndrome
- Whole body MRI
- Psychological questionnaires
-
Sutton, Surrey, United KingdomCancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022
Biomarker Monitoring in TP53 Mutation Carriers
Completed
- Li-Fraumeni Syndrome
- +2 more
-
La Jolla, CaliforniaScripps Clinic Medical Group
Sep 17, 2019
Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)
Not yet recruiting
- Obesity, Child
- sequencing of a panel of 14 genes in leptin melanocortin pathway
- (no location specified)
Jul 3, 2023
Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (The risk assessment questionnaire, Blood specimens, tumor
Recruiting
- Pancreatic Ductal Adenocarcinoma
- The risk assessment questionnaire
- +2 more
-
Basking Ridge, New Jersey
- +12 more
Dec 22, 2022
ANXA5 M2 Haplotyping in IVF Patients and Embryos
Recruiting
- Infertility
- +2 more
- M2 Test
-
North Brunswick, New JerseyGenomic Prediction Clinical Laboratory
Aug 1, 2022
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and
Recruiting
- Hereditary Breast and Ovarian Cancer
- Lynch Syndrome
- CASCADE genetic screening
-
Delémont, Jura, Switzerland
- +8 more
May 18, 2022
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma In Situ Trial in West Hollywood, Chicago, New York
Unknown status
- BRCA1 Mutation Carrier
- +8 more
- Telapristone Acetate
- +3 more
-
West Hollywood, California
- +2 more
Aug 16, 2019
Pancreas Cancer Trial
Completed
- Pancreas Cancer
- (no location specified)
May 11, 2022
Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)
Recruiting
- Prostate Cancer
- MS3TMRI / TRUS Guided Biopsy
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
May 5, 2022
Eardream Data Collection in Colombia Supported by ADDF
Recruiting
- Alzheimer Disease, Early Onset
- This is an observational study
-
Medellín, ColombiaFundacion Universitaria de Antioquia
Oct 5, 2022
BRCA and NACT in TNBC Patients
Completed
- Triple-Negative Breast Cancer
- BRCA1/2 genetic testing
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Hereditary Cancer, Breast Cancer, Ovarian Cancer Trial in Switzerland (Adapted Family Gene Toolkit, Targeted intervention)
Recruiting
- Hereditary Cancer
- +2 more
- Adapted Family Gene Toolkit
- Targeted intervention
-
Delémont, Jura, Switzerland
- +7 more
Nov 12, 2022